Halozyme Therapeutics Share Price Today
(NASDAQ: HALO)
Halozyme Therapeutics share price is $60.82 & ₹5,181.32 as on 30 Apr 2025, 2.30 'hrs' IST
$60.82
▲
0.25
(0.41%)
Market is closed - opens 7 PM, 30 Apr 2025
View live Halozyme Therapeutics share price in Dollar and Rupees. Guide to invest in Halozyme Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Halozyme Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Halozyme Therapeutics share price movements
- Today's Low: $59.53Today's High: $61.83
2.12%
Downside
Day's Volatility :3.71%
Upside
1.63%
- 52 Weeks Low: $37.9752 Weeks High: $66.00
37.58%
Downside
52 Weeks Volatility :42.48%
Upside
7.85%
Halozyme Therapeutics (HALO) Returns
Halozyme Therapeutics (HALO) Key Statistics
in dollars & INR
How to invest in Halozyme Therapeutics Stock (HALO) from India?
It is very easy for Indian residents to invest directly in Halozyme Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Halozyme Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Halozyme Therapeutics or HALO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Halozyme Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Halozyme Therapeutics shares which would translate to 0.014 fractional shares of Halozyme Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Halozyme Therapeutics, in just a few clicks!
Returns in Halozyme Therapeutics (HALO) for Indian investors in Rupees
The Halozyme Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Halozyme Therapeutics investment value today
Current value as on today
₹1,58,963
Returns
₹58,963
(+58.96%)
Returns from Halozyme Therapeutics Stock
₹56,874 (+56.87%)
Dollar Returns
₹2,089 (+2.09%)
Indian investors sentiment towards Halozyme Therapeutics (HALO)
Global Institutional Holdings in Halozyme Therapeutics
BlackRock Inc
14.26%
Vanguard Group Inc
10.78%
State Street Corp
5.83%
Snyder Capital Management LP
3.38%
Bank of America Corp
2.80%
AllianceBernstein L.P.
2.49%
Analyst Recommendation on Halozyme Therapeutics
Buy
82%Buy
17%Hold
0%Sell
Based on 17 Wall street analysts offering stock ratings for Halozyme Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Halozyme Therapeutics Stock (HALO)
What analysts predicted
Upside of 12.01%
Target:
$68.13
Current:
$60.82
Insights on Halozyme Therapeutics Stock (Ticker Symbol: HALO)
Price Movement
In the last 1 year, HALO stock has moved up by 56.1%Increasing Revenue
Revenue is up for the last 4 quarters, 195.87M → 298.00M (in $), with an average increase of 12.8% per quarterIncreasing Net Profit
Netprofit is up for the last 4 quarters, 76.82M → 137.01M (in $), with an average increase of 16.5% per quarterHALO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 16.9%HALO vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 91.0% return, outperforming this stock by 39.3%Price to Sales
ForHALO every $1 of sales, investors are willing to pay $7.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.
HALO Halozyme Therapeutics Financials in INR & Dollars
Halozyme Therapeutics Technicals Summary
Sell
Neutral
Buy
Halozyme Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Halozyme Therapeutics (HALO) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -5.14% | 19.65% | 58.87% | 48.18% | 161.24% |
 | -3.5% | -33.68% | -31.29% | -6.14% | 16.46% |
 | -8.24% | 21.23% | 62.23% | 49.96% | 78.11% |
 | 2.53% | 4.63% | 26.54% | 89.75% | 95.01% |
 | -5.61% | -9.46% | 77.05% | 83.29% | 97.62% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 17.66 | 17.66 | -2.5 | 5.0 | 1.98 | 0.18 | NA | 2.96 |
| 15.72 | 15.72 | 0.96 | 39.38 | 0.16 | 0.07 | 0.01 | 273.57 |
| NA | NA | NA | 1.1 | -0.19 | -0.06 | NA | 31.22 |
| 32.84 | NA | 1.35 | 17.95 | -0.03 | 0.13 | NA | 63.87 |
| NA | NA | -0.49 | 0.72 | -15.01 | -0.03 | NA | 0.52 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $7.5B | 161.24% | 17.66 | 43.74% |
| Buy | $65.6B | 16.46% | 15.72 | 31.07% |
| NA | $29.1B | 78.11% | NA | -16.92% |
| Buy | $127.0B | 95.01% | 32.84 | -4.86% |
| Buy | $32.6B | 97.62% | NA | -12.37% |
About Halozyme Therapeutics
Management People of Halozyme Therapeutics
Important FAQs about investing in HALO Stock from India :
What is Halozyme Therapeutics share price today?
Halozyme Therapeutics share price today stands at $60.82, Open: $60.11 ; Previous Close: $60.57 ; High: $61.83 ; Low: $59.53 ; 52 Week High: $66.00 ; 52 Week Low: $37.97.
The stock opens at $60.11, after a previous close of $60.57. The stock reached a daily high of $61.83 and a low of $59.53, with a 52-week high of $66.00 and a 52-week low of $37.97.
Can Indians buy Halozyme Therapeutics shares?
Yes, Indians can invest in the Halozyme Therapeutics (HALO) from India.
With INDmoney, you can buy Halozyme Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Halozyme Therapeutics at zero transaction cost.
How can I buy Halozyme Therapeutics shares from India?
It is very easy to buy Halozyme Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Halozyme Therapeutics (HALO) be purchased?
Yes, you can buy fractional shares of Halozyme Therapeutics with INDmoney app.
What are the documents required to start investing in Halozyme Therapeutics stocks?
To start investing in Halozyme Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Halozyme Therapeutics Stock (HALO)?
Today’s highest price of Halozyme Therapeutics (HALO) is $61.83.
Today’s lowest price of Halozyme Therapeutics (HALO) is $59.53.
What is today's market capitalisation of Halozyme Therapeutics?
What is the 52 Week High and Low Range of Halozyme Therapeutics Stock (HALO)?
52 Week High
$66.00
52 Week Low
$37.97
What are the historical returns of Halozyme Therapeutics (HALO)?
1 Month Returns
-5.14%
3 Months Returns
19.65%
1 Year Returns
58.87%
5 Years Returns
161.24%
Who is the Chief Executive Officer (CEO) of Halozyme Therapeutics ?
Discover More
Brunswick Corporation$46.36
-0.3%
Laureate Education Inc$20.36
+3.14%
Nnn Reit Inc.$41.38
+0.63%
Outfront Media Inc.$15.37
+0.07%
Artisan Partners Asset Management Inc.$37.56
+0.91%
Evolent Health, Inc. - Class A Shares$9.84
+5.35%
Ishares Msci Min Vol Global Etf$116.29
+0.53%
Quidelortho Corp$28.58
-1.31%
Silicon Laboratories Inc$101.72
-0.88%